Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

Total article views   HTML views PDF downloads Totals
6,785 Dovepress* 6,309+ 1,355 7,664
PubMed Central* 476 223 699
Totals 6,785 1,578 8,363
*Since 19 September 2018

View citations on PubMed Central and Google Scholar